Genetic Variants Affect Distinct Metabolic Pathways in Pediatric Multisystem Inflammatory Syndrome and Severe...

Area of Science:

• Genetics
• Immunology
• Pediatrics

Background:

• The COVID-19 pandemic caused a global health crisis, with children generally experiencing milder symptoms.
• Multisystem inflammatory syndrome in children (MIS-C) is a rare but serious complication developing weeks after SARS-CoV-2 infection.
• Understanding the genetic basis of severe COVID-19 and MIS-C in children is crucial for targeted interventions.

Purpose of the Study:

• To identify genetic variants associated with severe COVID-19 and MIS-C in unvaccinated children with acute respiratory distress syndrome (ARDS).
• To explore potential biological pathways implicated in these pediatric COVID-19 complications.

Main Methods:

• Whole-exome sequencing was performed on pediatric patients with ARDS due to COVID-19.
• Over-representation analysis was used to identify enriched genetic variants and pathways.
• Genetic findings were compared between severe COVID-19 and MIS-C patient groups.

Main Results:

• Enrichment of potentially pathogenic genetic variants in carbohydrate metabolism genes (glycogen breakdown) was observed in severe COVID-19 pediatric patients.
• Enrichment of genetic variants in cholesterol and lipoprotein metabolism genes was found in MIS-C patients.
• These findings highlight distinct genetic predispositions for different pediatric COVID-19 outcomes.

Conclusions:

• Genetic factors play a role in the diverse clinical presentations of COVID-19 in children.
• Carbohydrate and lipid metabolism pathways are implicated in severe COVID-19 and MIS-C.
• Further research into these genetic underpinnings may reveal novel therapeutic targets.